BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25903641)

  • 1. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.
    Klaassen I; Özgören B; Sadowski CE; Möller K; van Husen M; Lehnhardt A; Timmermann K; Freudenberg F; Helmchen U; Oh J; Kemper MJ
    Pediatr Nephrol; 2015 Sep; 30(9):1477-83. PubMed ID: 25903641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
    Büscher AK; Kranz B; Büscher R; Hildebrandt F; Dworniczak B; Pennekamp P; Kuwertz-Bröking E; Wingen AM; John U; Kemper M; Monnens L; Hoyer PF; Weber S; Konrad M
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
    Hamasaki Y; Yoshikawa N; Nakazato H; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Ito S; Kaneko T; Honda M;
    Pediatr Nephrol; 2013 May; 28(5):765-71. PubMed ID: 23314441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
    Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
    Shatat IF; Schoeneman M; Flynn JT; Woroniecki RP
    Pediatr Nephrol; 2007 Jun; 22(6):834-9. PubMed ID: 17294224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-resistant nephrotic syndrome: impact of genetic testing.
    Kari JA; El-Desoky SM; Gari M; Malik K; Vega-Warner V; Lovric S; Bockenhauer D
    Ann Saudi Med; 2013; 33(6):533-8. PubMed ID: 24413855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
    Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
    Cao Q; Huang WY; Xu H; Zhou LJ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.